Trastuzumab: Fetal anhydramnios following in utero exposure: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1417, 2012-01, pp. : 43-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab: Anhydramnios and fetal growth retardation following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Trastuzumab: Anhydramnios, and fatal pulmonary hypoplasia and atelectasis following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Paclitaxel/trastuzumab: Anhydramnios and renal failure in a fetus following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil: Anhydramnios, and fatal congenital abnormalities following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Valproic acid: Fetal valproate syndrome following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 33-34

Adis International

Access to resources Recommend Favorite